News
The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...
First-ever clinical trial exclusively conducted among people with hard-to-treat form of tuberculosis known as pre-extensively ...
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to TSND-201 (methylone) for the treatment of posttraumatic stress disorder (PTSD).
Most people don’t need to be concerned about the plague based on a recent death in Arizona. But take precautions if you live ...
A person in Arizona recently died of pneumonic plague—a rare and severe form of the disease. An expert explains how the ...
No improvement in clinical outcomes occurred among inpatients with COVID-19 who received nirtmatrelvir-ritonavir or molnupiravir in addition to usual care.
This article advocates for the widespread adoption of Tranexamic Acid (TXA) across all levels of military medical care.
3don MSN
A protein called PAR1 helps lymphatic vessels structurally transform to boost fluid drainage and support healing when the ...
“When CPAP isn’t a good fit, other options such as oral appliance therapy or surgery become important alternatives,” Withrow ...
4d
The Asian Parent on MSNMarfan Syndrome in Children: Abnormal Height Is One of the SymptomsSindrom Marfan bisa terjadi pada si kecil. Anak yang berisiko mengidap penyakit ini adalah yang memiliki orang tua dengan ...
Chronic thromboembolic pulmonary hypertension (CTEPH) is the clinical term for high blood pressure in the lungs caused by blockages, such as clots, in the blood vessels. Although CTEPH therapies have ...
Infliximab and efzofitimod may be effective in pulmonary sarcoidosis and tofacitinib and adalimumab in cutaneous sarcoidosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results